We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LM
1126
DELISTED
Legg Mason, Inc.
LM
$448K 0.02%
9,008
+6,449
+252% +$320K
ALE
1127
DELISTED
Allete
ALE
$446K 0.02%
+8,151
New +$462K
BURL icon
1128
Burlington
BURL
$23.2B
$446K 0.02%
2,264
+2,076
+1,104% +$391K
MWA icon
1129
Mueller Water Products
MWA
$4.16B
$446K 0.02%
+47,299
New +$424K
MDRX
1130
DELISTED
Veradigm Inc. Common Stock
MDRX
$446K 0.02%
65,871
+64,725
+5,648% +$420K
FSTA icon
1131
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$445K 0.02%
+12,752
New +$441K
CCXI
1132
DELISTED
ChemoCentryx, Inc.
CCXI
$444K 0.02%
+7,721
New +$420K
X
1133
DELISTED
US Steel
X
$443K 0.02%
61,353
-75,361
-55% -$588K
IVOG icon
1134
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.71B
$441K 0.02%
6,332
-17,616
-74% -$1.13M
TRC icon
1135
Tejon Ranch
TRC
$451M
$440K 0.02%
+30,572
New +$426K
HCA icon
1136
HCA Healthcare
HCA
$89.5B
$439K 0.02%
4,521
+4,424
+4,561% +$460K
HL icon
1137
Hecla Mining
HL
$11.3B
$439K 0.02%
134,205
+132,105
+6,291% +$365K
TRIP icon
1138
TripAdvisor
TRIP
$1.26B
$439K 0.02%
23,076
+12,712
+123% +$243K
KYNB
1139
Kyntra Bio
KYNB
$29.4M
$438K 0.02%
+432
New +$401K
SFNC icon
1140
Simmons First National
SFNC
$3.39B
$438K 0.02%
+25,578
New +$438K
FLG
1141
Flagstar Bank National Association
FLG
$5.82B
$438K 0.02%
14,332
+13,961
+3,763% +$420K
AIV
1142
Aimco
AIV
$383M
$437K 0.02%
87,086
+86,335
+11,496% +$428K
TAP icon
1143
Molson Coors Class B
TAP
$8.09B
$437K 0.02%
12,718
+12,618
+12,618% +$504K
CBRE icon
1144
CBRE Group
CBRE
$42.9B
$436K 0.02%
9,628
-4,225
-30% -$182K
PSR icon
1145
Invesco Active US Real Estate Fund
PSR
$60M
$436K 0.02%
5,411
+2,945
+119% +$229K
CMI icon
1146
Cummins
CMI
$88.7B
$435K 0.02%
2,511
-3,230
-56% -$516K
BIDU icon
1147
Baidu
BIDU
$37.2B
$434K 0.02%
+3,618
New +$387K
CTXS
1148
DELISTED
Citrix Systems Inc
CTXS
$434K 0.02%
2,935
+2,346
+398% +$338K
BRX icon
1149
Brixmor Property Group
BRX
$9.32B
$433K 0.02%
+33,764
New +$382K
NWE icon
1150
NorthWestern Energy
NWE
$4.43B
$432K 0.02%
+7,929
New +$459K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.